title: Virus elimination and histologic improvement in patients with chronic hepatitis C treated with interferon alpha.
abstract: We evaluated the elimination of hepatitis C virus (HCV) by means of interferon alpha (IFN-alpha) by investigating both positive- and negative-stranded RNA forms in the peripheral blood mononuclear cells and liver tissue. We also assessed the long-term histologic improvement accompanying viral clearance. We studied 20 persons with HCV whose serum aminotransferase levels remained normal for more than 1.5 years after IFN-alpha treatment withdrawal. The presence of HCV RNA in their peripheral blood and of both positive and negative strands in the peripheral blood mononuclear cells and liver tissue was investigated using the reverse transcription polymerase chain reaction method. We examined the histologic findings using the European classification and the histology activity index scoring system. In 16 of 20 patients, both strands disappeared from the possible reservoirs. The histologic findings indicated reduced activity, and histology activity index scores (1, 2, 3, and total) also showed significant improvement. We confirmed that IFN-alpha therapy can induce the elimination of HCV RNA from the conceivable HCV reservoirs and effect histologic improvement. Therapy with IFN-alpha is effective for treating chronic hepatitis C.
authors.affiliation: First Department of Internal Medicine, Osaka Medical College, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Teramura
authors.forename: A
authors.initials: A
authors.lastname: Fukuda
authors.forename: H
authors.initials: H
authors.lastname: Kobayashi
authors.forename: S
authors.initials: S
authors.lastname: Yoshimoto
authors.forename: H
authors.initials: H
authors.lastname: Kawashima
authors.forename: N
authors.initials: N
authors.lastname: Ohsawa
mesh_terms: D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D005260:Female; D005355:Fibrosis / Q000473:pathology; D005500:Follow-Up Studies; D016174:Hepacivirus / Q000302:isolation & purification; D006526:Hepatitis C / Q000188:drug therapy / Q000473:pathology* / Q000821:virology*; D006521:Hepatitis, Chronic / Q000188:drug therapy / Q000473:pathology* / Q000821:virology*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D007963:Leukocytes, Mononuclear / Q000821:virology; D008099:Liver / Q000821:virology; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000032:analysis; D014158:Transcription, Genetic; D019562:Viral Load
chemical_list: D016898:Interferon-alpha; D012367:RNA, Viral; D000410:Alanine Transaminase